NCT06716853
A Clinical Gene Therapy Study with Hematopoietic Stem Cells for the Treatment, with Single Dose of Temferon, of Patients Suffering from Metastatic Renal Cell Carcinoma
Phase: Phase 1/2
Role: Collaborator
Start: Oct 22, 2024
Completion: Sep 30, 2026